Amylyx Pharmaceuticals Inc

NASDAQ:AMLX   3:59:51 PM EDT
8.51
+0.06 (+0.71%)
Earnings Announcements

Amylyx Pharmaceuticals Reports First Quarter 2022 Financial Results

Published: 05/12/2022 20:59 GMT
Amylyx Pharmaceuticals Inc (AMLX) - Amylyx Pharmaceuticals Reports First Quarter 2022 Financial Results.
Amylyx Pharmaceuticals Inc- Qtrly Loss per Share $0.93.
Revenue is expected to be $0.08 Million
Adjusted EPS is expected to be -$0.86

Next Quarter Revenue Guidance is expected to be $3.82 Million
Next Quarter EPS Guidance is expected to be -$0.81

More details on our Analysts Page.